These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29242929)

  • 21. Molecular markers of breast axillary lymph node metastasis.
    Cavalli LR
    Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sentinel lymph node reevaluation].
    Siewert JR
    Chirurg; 2004 Aug; 75(8):749-50. PubMed ID: 15515215
    [No Abstract]   [Full Text] [Related]  

  • 25. Contemporary management of the axilla in breast cancer.
    Nurudeen S; Hunt KK
    Clin Adv Hematol Oncol; 2018 Dec; 16(12):823-831. PubMed ID: 30843891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer.
    Jansen L; Doting MH; Rutgers EJ; de Vries J; Olmos RA; Nieweg OE
    Br J Surg; 2000 Jul; 87(7):920-5. PubMed ID: 10931029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contralateral axillary metastases from breast cancer. Personal experience and review of literature.
    Pasta V; Urciuoli P; D'Orazi V; Sottile D; Monti M; Redler A
    Ann Ital Chir; 2014; 85(3):260-4. PubMed ID: 24662239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative nodal irradiation in breast cancer patients with 1 to 3 axillary lymph nodes involved: the debate continues….
    Marta GN; de Moraes FY
    Expert Rev Anticancer Ther; 2015; 15(11):1257-9. PubMed ID: 26502180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel nodes outside level I-II of the axilla and staging in breast cancer.
    Rönka R; Krogerus L; Leppänen E; Smitten KV; Leidenius M
    Anticancer Res; 2002; 22(5):3109-12. PubMed ID: 12530052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An axillary score (Barranger Score) to predict nonsentinel node metastasis in breast cancer patients with positive sentinel node.
    Coutant C; Uzan S; Morel O; Malartic C; Akerman G; Barranger E
    Am J Surg; 2008 Jan; 195(1):135-6. PubMed ID: 18070736
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla -- a lesson from the past -- contribution to the concept of axillary reverse mapping.
    Pavlista D; Eliska O
    Eur J Surg Oncol; 2012 May; 38(5):390-4. PubMed ID: 22336143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatics of the breast and the rationale for different injection techniques.
    Nieweg OE
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):71S-73S. PubMed ID: 11599906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prognostic significance of axillary node metastasis in breast cancer].
    Miura S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():36-42. PubMed ID: 8702309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and treatment decisions in axillary-node-negative breast cancer.
    McGuire WL; Clark GM
    N Engl J Med; 1992 Jun; 326(26):1756-61. PubMed ID: 1594018
    [No Abstract]   [Full Text] [Related]  

  • 35. Sentinel node biopsy in breast cancer.
    Benson JR; Rovere GQ
    Lancet; 2001 Nov; 358(9295):1815. PubMed ID: 11734271
    [No Abstract]   [Full Text] [Related]  

  • 36. Axillary dissection over the years: where to from here?
    Keshtgar MR; Baum M
    World J Surg; 2001 Jun; 25(6):761-6. PubMed ID: 11376413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodal treatment for patients with early stage breast cancer: guilty or innocent?
    Recht A
    Radiother Oncol; 1992 Oct; 25(2):79-82. PubMed ID: 1438938
    [No Abstract]   [Full Text] [Related]  

  • 38. Axillary reverse mapping (ARM): where to go.
    Shao X; Sun B; Shen Y
    Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of node-negative breast cancer in patients treated in a community hospital.
    Hahneman BM; Thompson SJ; Babcock WH; Salters S
    J S C Med Assoc; 1989 Dec; 85(12):560-4. PubMed ID: 2615325
    [No Abstract]   [Full Text] [Related]  

  • 40. Breast cancer: can axillary lymph node dissection be avoided?
    Barry M; Kell MR
    Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.